‘Worst imaginable’ brain tumor yields, in some young people, to CAR-T therapy

A rare promising step against surgery-resistant gliomas

November 15, 2024 Check out STAT+

Sponsored By

Wikimedia Commons STAT+ | 'Worst imaginable' brain tumor yields, in some young people, to CAR-T therapy A CAR-T trial is one of several efforts that suggest there's hope of treating the "worst imaginable childhood brain tumor," known as DIPG.   By Jason Mast STAT+ | Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster The drug, from Shanghai-based LaNova Medicines, targets PD-1 and VEGF, an approach a number of experimental drugs are taking. By Matthew Herper and Adam Feuerstein Opinion: How chaplains can help the fractured U.S. health care system Hospitals should support chaplains, who can aid countless patients and families facing impossible-seeming conversations and decisions. By Robert Klitzman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser